Tag: Stem Cells
Untreated Oral Infection Not Tied to Stem Cell Transplant Outcomes
Untreated oral infections pretransplant not linked to post-HSCT survival during six-month follow-up
ASH: AlloHSCT Feasible After PD-1, PD-L1 mAb in Hodgkin Lymphoma
Outcomes good for those treated with a PD-1 or PD-L1 inhibitor before undergoing allogeneic HSCT
Many Multiple Sclerosis Patients Considering Stem Cell Transplant
However, many are not well-informed regarding stem cell transplants
Use of Novel Therapy, Stem Cell Transplant in MM Varies by Race
African-Americans, Hispanics have longer time from MM diagnosis to novel therapy initiation than whites
Salvage Therapy Does Not Up Survival for Progressive Myeloma
Deepening of response through salvage therapy not linked to improved progression-free, overall survival
ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma
Autologous stem cell transplantation explored for high-risk, early therapy failure FL prior to rituximab use
Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21-month follow-up after autologous HSCT
Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML
In active AML, outcomes superior for allo-HCT with unrelated donor than for cord blood transplantation
Experts Develop Standardized Tool for Describing Cell Therapies
Consensus reached on contents of DOSES tool for improving standardization and transparency
Population Mortality Affects Long-Term Follow-Up of AlloHCT
Substantial part of total nonrelapse mortality for older patients due to population mortality
